Horizon Therapeutics Plc Operating Income

As of the most recent data (June 2023), HZNP shows a operating income of $530M. That compares with $900M in the prior-year period — down 41.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HZNP's operating income is now $530M (was $900M) — a 41.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Horizon Therapeutics Plc is outperforming or lagging.

Tracking HZNP's operating income over time shows whether Horizon Therapeutics Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $530M That compares with $900M in the prior-year period — down 41.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Horizon Therapeutics Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $530M) with ownership activity and broader fundamentals.

Horizon Therapeutics Plc's operating income is $530M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.